Therefore, targeting the Shh‐Gli pathway through dual inhibition (smoothened and Gli) by α‐Mangostin could have enormous clinical significance for pancreatic cancer initiation, progression, metastasis and tumour growth. This evidence concerns the gene GLI1 and familial pancreatic carcinoma.